FORT LAUDERDALE, Fla.,
Dec. 6, 2016 /PRNewswire/
-- Ocean Bio-Chem, Inc. (NASDAQ: OBCI) announced today the
Center for Disease Control and Prevention (CDC) recently announced
that drug resistant Candida auris infections have been
identified in hospitals in the United States. The CDC report
went on to state that C. auris infections tends to occur in
hospitalized patients and can be resistant to antifungal
drugs. In the announcement, the CDC recommended thorough daily
and after-discharge cleaning of rooms of C. auris patients
using EPA registered hospital disinfectants active against
fungi.
In addition to the CDC recommendations, on November 28th, the EPA which is
responsible for regulating hospital disinfectants and other
antimicrobial pesticides used in healthcare facilities issued
recommendations for using hospital disinfectant products with
fungal claims, which should be effective against C.
auris. PERFORMACIDE® Hard Surface Disinfectant
(EPA Registration. No. 87508-3) is a hospital grade
Disinfectant/Fungicide/Tuberculocide/Virucide that meets these
recommendations.
PERFORMACIDE® uses a liquid chlorine dioxide
solution that can be easily prepared by combining tap water and a
patented pouch system in a ready to use trigger spray bottle.
Because the activated solution does not leave harmful residues,
rinsing of treated surfaces is not required once the product has
been allowed to air dry. Ocean Bio-Chem is currently shipping
PERFORMACIDE® through online retailers as well as
distributors.
Peter Dornau went on to say "With
the many drug resistant outbreaks becoming more commonplace, it is
critical that hospitals and health care facilities review their
standard operating practices to include
PERFORMACIDE® and prevent future
outbreaks."
About Ocean Bio-Chem, Inc.:
Ocean Bio-Chem, Inc. manufactures, markets and distributes a
broad line of appearance and maintenance products for the marine,
automotive, power sports, recreational vehicle and outdoor power
equipment markets under the Star brite®, Star Tron®, Odor Star®,
Outdoor Collection and other brand names within the United States of America and Canada. In addition, the Company produces
private label formulations of many of its products for various
customers and provides custom blending and packaging services for
these and other products. The Company also manufactures, markets
and distributes a line of disinfectant, sanitizing and deodorizing
products under the Star brite® and
Performacide® brand names.
The Company trades publicly under NASDAQ Capital Markets, Ticker
Symbol: OBCI.
The Company's web sites are: www.oceanbiochem.com,
www.starbrite.com; www.startron.com; www.nos-guard.com,
www.performacide.com
Forward-looking Statements:
Certain statements contained in this Press Release, including
without limitation, our ability to market and sell
Performacide® in the hospital and health care sectors
constitute forward-looking statements. For this purpose, any
statements contained in this report that are not statements of
historical fact may be deemed to be forward-looking statements.
Without limiting the generality of the foregoing, words such as
"believe," "may," "will," "expect," "anticipate," "intend," or
"could," including the negative or other variations thereof or
comparable terminology, are intended to identify forward-looking
statements. These statements involve known and unknown risks,
uncertainties and other factors which may cause actual results to
be materially different from those expressed or implied by such
forward-looking statements. Factors that may affect these results
include, but are not limited to, the highly competitive nature of
our industry; reliance on certain key customers; changes in
consumer demand for marine, recreational vehicle and automotive
products; advertising and promotional efforts; unanticipated
litigation developments; exposure to market risks relating to
changes in interest rates, foreign exchange rates, prices for raw
materials that are petroleum or chemical based and other factors
addressed in Part I, Item 1A ("Risk Factors") in our annual report
on Form 10-K for the year ended December 31,
2015.
Contact:
Peter Dornau
CEO and President
pdornau@starbrite.com
954-587-6280
Jeff Barocas
Vice President & CFO
Jbarocas@starbrite.com
954-587-6280
Photo - http://photos.prnewswire.com/prnh/20161205/445752
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/performacide-meets-the-center-for-disease-control-and-prevention-recommendations-for-the-environmental-control-of-candida-auris-300373587.html
SOURCE Ocean Bio-Chem, Inc.